Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-07

Clinical Trial Update: Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers. [Phase 4]

View source ↗

Summary

A Phase 4 trial sponsored by Royal Biologics is evaluating Amnio-Maxx for healing diabetic foot ulcers; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amnio-Maxx

Snippet

Sponsor: Royal Biologics | Conditions: Diabetic Foot Ulcer (DFU), Amnio-Maxx | Phase 4 | Status: RECRUITING